Fitterfly Secures $12M Series A Boost to Revolutionize Digital Therapeutics and Personalized Health

Fitterfly, a pioneering health tech start-up specializing in Digital Therapeutics (DTx), is proud to announce a successful funding round that raised INR 12,000,000. This exciting milestone underscores the market’s confidence in Fitterfly’s unique approach to healthcare, which blends advanced technological solutions with personalized care, delivered by a team of doctors, engineers, and senior nutritionists. With a mission to improve patient outcomes, Fitterfly has developed a suite of hyper-personalized DTx programs that support individuals battling prediabetes, diabetes, and obesity. These programs, designed as an add-on to traditional medical therapy, provide 360° guidance around nutrition, exercise, and mental well-being—a holistic strategy powered by scientifically driven interventions and behavioral change techniques inspired by the Nudge Theory. The secured funds will primarily be channeled towards scaling and enhancing these digital therapeutics offerings, enabling Fitterfly to reach more patients and deepen its impact within the healthcare ecosystem. Investment will also be directed towards expanding the company’s intellectual property in the nutrition and food database arena, currently a key resource for top pharmaceutical and nutraceutical companies. Fitterfly’s innovative platform, which connects nutrition, exercise, and mental well-being through a network of expert coaches, clinical psychologists, nutritionists, and physiotherapists, is poised for further growth with this fresh capital injection. Operating from Navi Mumbai, Surat, and Gurgaon, along with a robust remote workforce across India, Fitterfly is set to revolutionize digital healthcare. We invite you to learn more about our transformative DTx programs and our vision for a healthier future at www.fitterfly.com.